Thursday, September 23, 2021
- Advertisement -spot_img

TAG

Sputnik V

Dr Reddy’s expects first lot of Russia’s COVID-19 vaccine Sputnik V by May end

RDIF CEO Kirill Dmitriev in a virtual press conference recently said he expected over 50 million doses of Sputnik V vaccine to be manufactured in India by this summer.

Delayed move

Govt must now work out a mutually agreeable pricing and procurement strategy for a smooth rollout of the foreign vaccines

DCGI accords Dr. Reddy’s permission to import Sputnik V

According to the Hyderabad-based company, emergency use will be as per the provisions of the new drug and clinical trials rules, 2019 under the Drugs and Cosmetics Act

India to produce 850 million Sputnik doses annually: RDIF

India has become the 60th country to approve Sputnik V, RDIF, Russia's sovereign wealth fund, said in a statement.

Russia’s Sputnik V gets Emergency Use Authorisation nod in India

The decision comes after the Drugs Controller General of India (DCGI)'s SEC met today to take up Sputnik V application for EUA in India.

RDIF, Hyderabad-based Virchow Biotech ink pact to produce Sputnik V vaccine in India

Four companies developing Covid vaccines in India are based in Hyderabad

Western groups plan disinformation campaign against Russian vax

Such a campaign was made by non-governmental organisations and media in the West, the outlets reported on Friday citing a high-ranking source in the Kremlin as saying.

C-vax: WHO chief appreciates Russia’s investment in science

I had a constructive call with Mihail Murashko (Mikhail Murashko), Russia's Health Minister, about the Covid19 response globally & in Russia, as well as about the Sputnik V vaccine & the WHO Emergency Use Listing process for vaccines.

Dr Reddy’s Lab seeks emergency use authorisation for Sputnik V

As part of the review process, the drug major will present the safety profile of phase 2 study, and interim data of phase 3 trial, which is expected to be complete by February 21

Sputnik V vaccine shows 91.6% efficacy in phase 3 trials: Lancet

Data on 19,866 volunteers were included in the efficacy analysis - 14,964 of whom received the vaccine and 4,902 the placebo.

Dr Reddy’s to launch Sputnik V under EUA by March

The bridging phase II and phase III study on 1,600 subjects in India is assessing immunogenicity and safety.

Pakistan approves emergency use of Sputnik V COVID-19 vaccine

Sputnik V is the third vaccine to be approved for the emergency use in the country, the report said.

Dr Reddy’s gets DCGI nod for phase 3 trial for Sputnik V vaccine

The trial will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in India

India to produce 300 million doses of Sputnik V vaccine

Sputnik V, the world's first COVID-19 vaccine, is over 95 per cent effective, said Russian President Vladimir Putin on Thursday.

No alcohol for 2 months after Covid vaccine, experts tell why

According to the experts, warning against alcohol consumption that has been issued is a general immune-boosting measure rather than as a specific contraindication or interaction with the vaccine.

No alcohol for 2 months after Covid vax, experts tell why

According to the experts, warning against alcohol consumption that has been issued is a general immune-boosting measure rather than as a specific contraindication or interaction with the vaccine.

Britain starts virus jabs as Biden vows 100 million vaccinations

The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5 million people worldwide and ravaged economies.

Russia to produce Sputnik V Covid vaccine in India

According to the RDIF -- Russia's sovereign wealth fund, the vaccine's interim clinical trial results show 95 per cent efficacy on the 42nd day after the first dose.

Tipping point

Developments on vaccine front offer a tentative timeline on when it could be available on a mass scale

Russian vaccine arrives in India for human clinical trial

The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries.

Latest news

- Advertisement -spot_img
Telangana Today